These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 1425868)
1. Factors in hydrazine formation from isoniazid by paediatric and adult tuberculosis patients. Gent WL; Seifart HI; Parkin DP; Donald PR; Lamprecht JH Eur J Clin Pharmacol; 1992; 43(2):131-6. PubMed ID: 1425868 [TBL] [Abstract][Full Text] [Related]
2. Levels of acetyl hydrazines and rate of acetylation of isoniazid in adult tuberculosis patients. Bhalerao EB; Bhide SV Indian J Physiol Pharmacol; 1985; 29(2):83-8. PubMed ID: 4093196 [TBL] [Abstract][Full Text] [Related]
3. [Type of isoniazid (INH) acetylation determined in tuberculosis patients treated at the Institute of Tuberculosis and Lung Diseases in Warsaw during the years 1990-1997]. Augustynowicz-Kopeć E; Zwolska Z Pneumonol Alergol Pol; 2002; 70(3-4):180-92. PubMed ID: 12271965 [TBL] [Abstract][Full Text] [Related]
4. Hydrazine production in children receiving isoniazid for the treatment of tuberculous meningitis. Donald PR; Seifart HI; Parkin DP; van Jaarsveld PP Ann Pharmacother; 1994 Dec; 28(12):1340-3. PubMed ID: 7696721 [TBL] [Abstract][Full Text] [Related]
5. Determination of the acetylator phenotype in Moroccan tuberculosis patients using isoniazid as metabolic probe. Aït Moussa L; Khassouani CE; Hüe B; Jana M; Bégaud B; Soulaymani R Int J Clin Pharmacol Ther; 2002 Dec; 40(12):548-53. PubMed ID: 12503812 [TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid isoniazid concentrations in children with tuberculous meningitis: the influence of dosage and acetylation status. Donald PR; Gent WL; Seifart HI; Lamprecht JH; Parkin DP Pediatrics; 1992 Feb; 89(2):247-50. PubMed ID: 1734391 [TBL] [Abstract][Full Text] [Related]
7. Rifampin-induced release of hydrazine from isoniazid. A possible cause of hepatitis during treatment of tuberculosis with regimens containing isoniazid and rifampin. Sarma GR; Immanuel C; Kailasam S; Narayana AS; Venkatesan P Am Rev Respir Dis; 1986 Jun; 133(6):1072-5. PubMed ID: 3717759 [TBL] [Abstract][Full Text] [Related]
8. Plasma hydrazine concentrations in man after isoniazid and hydralazine administration. Blair IA; Mansilla Tinoco R; Brodie MJ; Clare RA; Dollery CT; Timbrell JA; Beever IA Hum Toxicol; 1985 Mar; 4(2):195-202. PubMed ID: 4007883 [TBL] [Abstract][Full Text] [Related]
9. [The potential clinical significance of the isoniazid acetylator phenotype in the treatment of pulmonary tuberculosis]. Ellard GA Rev Mal Respir; 1984; 1(4):207-19. PubMed ID: 6505358 [TBL] [Abstract][Full Text] [Related]
10. Predisposing factors in hepatitis induced by isoniazid-rifampin treatment of tuberculosis. Grönhagen-Riska C; Hellstrom PE; Fröseth B Am Rev Respir Dis; 1978 Sep; 118(3):461-6. PubMed ID: 707874 [TBL] [Abstract][Full Text] [Related]
12. A Physiologically Based Pharmacokinetic Model of Isoniazid and Its Application in Individualizing Tuberculosis Chemotherapy. Cordes H; Thiel C; Aschmann HE; Baier V; Blank LM; Kuepfer L Antimicrob Agents Chemother; 2016 Oct; 60(10):6134-45. PubMed ID: 27480867 [TBL] [Abstract][Full Text] [Related]
13. The early bactericidal activity of isoniazid related to its dose size in pulmonary tuberculosis. Donald PR; Sirgel FA; Botha FJ; Seifart HI; Parkin DP; Vandenplas ML; Van de Wal BW; Maritz JS; Mitchison DA Am J Respir Crit Care Med; 1997 Sep; 156(3 Pt 1):895-900. PubMed ID: 9310010 [TBL] [Abstract][Full Text] [Related]
14. Lack of relationship between hepatic toxicity and acetylator phenotype in three thousand South Indian patients during treatment with isoniazid for tuberculosis. Gurumurthy P; Krishnamurthy MS; Nazareth O; Parthasarathy R; Sarma GR; Somasundaram PR; Tripathy SP; Ellard GA Am Rev Respir Dis; 1984 Jan; 129(1):58-61. PubMed ID: 6367570 [TBL] [Abstract][Full Text] [Related]
15. Isoniazid disposition, comparison of isoniazid phenotyping methods in and acetylator distribution of Japanese patients with idiopathic systemic lupus erythematosus and control subjects. Horai Y; Ishizaki T; Sasaki T; Koya G; Matsuyama K; Iguchi S Br J Clin Pharmacol; 1982 Mar; 13(3):361-74. PubMed ID: 7059436 [TBL] [Abstract][Full Text] [Related]
16. [Isoniazid acetylation in a group of Tunisian patients. Report of 620 patients]. Mehiri BR; Zouaoui A; Chérif J; Ourari B; Daghfous R; Oueslati MH; Louzir B; Daghfous J; Chelbi B; Béji M Tunis Med; 2005 Jul; 83(7):385-9. PubMed ID: 16220693 [TBL] [Abstract][Full Text] [Related]
17. The disposition of antituberculous drugs in plasma of elderly patients. I. Isoniazid and hydrazine metabolite. Walubo A; Chan K; Woo J; Chan HS; Wong CL Methods Find Exp Clin Pharmacol; 1991 Oct; 13(8):545-50. PubMed ID: 1956209 [TBL] [Abstract][Full Text] [Related]
18. Hydrazine--a possible cause of isoniazid--induced hepatic necrosis. Woo J; Chan CH; Walubo A; Chan KK J Med; 1992; 23(1):51-9. PubMed ID: 1573341 [TBL] [Abstract][Full Text] [Related]
19. Role of hydrazine in the mechanism of isoniazid hepatotoxicity in rabbits. Sarich TC; Youssefi M; Zhou T; Adams SP; Wall RA; Wright JM Arch Toxicol; 1996; 70(12):835-40. PubMed ID: 8911642 [TBL] [Abstract][Full Text] [Related]
20. Determination of the isoniazid acetylator phenotype in a West African population. Salako LA; Aderounmu AF Tubercle; 1977 Jun; 58(2):109-12. PubMed ID: 878015 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]